butylscopolammonium bromide has been researched along with delphinidin in 1 studies
| Studies (butylscopolammonium bromide) | Trials (butylscopolammonium bromide) | Recent Studies (post-2010) (butylscopolammonium bromide) | Studies (delphinidin) | Trials (delphinidin) | Recent Studies (post-2010) (delphinidin) |
|---|---|---|---|---|---|
| 695 | 165 | 149 | 3,889 | 99 | 939 |
| Protein | Taxonomy | butylscopolammonium bromide (IC50) | delphinidin (IC50) |
|---|---|---|---|
| Epidermal growth factor receptor | Homo sapiens (human) | 0.0063 | |
| Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | 0.0051 | |
| Alpha-synuclein | Homo sapiens (human) | 6.5 | |
| Lactoylglutathione lyase | Homo sapiens (human) | 1.9 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baum, U; Dittler, HJ; Fink, U; Gerhardt, P; Helmberger, H; Herter, B; Schulte, B; Sendler, A | 1 |
1 other study(ies) available for butylscopolammonium bromide and delphinidin
| Article | Year |
|---|---|
Adenocarcinoma of the gastro-esophageal junction: CT for monitoring during neoadjuvant chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Butylscopolammonium Bromide; Chemotherapy, Adjuvant; Contrast Media; Emulsions; Esophageal Neoplasms; Esophagogastric Junction; Esophagoscopy; Fasting; Female; Gastrointestinal Agents; Gastroscopy; Glucagon; Humans; Injections, Intravenous; Male; Middle Aged; Muscarinic Antagonists; Paraffin; Pharmaceutic Aids; Radiography, Interventional; Single-Blind Method; Stomach Neoplasms; Tomography, X-Ray Computed; Triiodobenzoic Acids | 1996 |